Our results showed that WDR5 knockdown or inactivity reversed the down-regulated sensitivity of CRC cells to oxaliplatin caused by TOX3 overexpression, while WDR5 overexpression desensitized cancer cells to oxaliplatin based on TOX3 knockdown (Fig 5H). The gene discussed is TOX3; the disease is cancer.